Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Glufor vs Glucophage (Metformin) in Healthy Subjects
NCT05753371Phase 1Completed
- Sponsor
- PT Pyridam Farma Tbk
- Start
- Feb 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Glucofree in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by PT Pyridam Farma Tbk. Primary endpoint: Geometric Mean Ratio of Pharmacokinetic Parameters. Started Feb 2022; status: completed.
02
Drugs
Glucofree
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05753371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753371.